Page last updated: 2024-08-21

isoxazoles and Central Nervous System Neoplasm

isoxazoles has been researched along with Central Nervous System Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamson, PC; Balis, FM; Blaney, SM; Cropp, GF; Gillespie, AF; Hannah, AL; Kitchen, B; Murphy, RF; Patel, M; Whitcomb, PG; Widemann, BC	1

Trials

1 trial(s) available for isoxazoles and Central Nervous System Neoplasm

Article	Year
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6 Topics: Adolescent; Adult; Aniline Compounds; Antineoplastic Agents; Central Nervous System Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Nitriles; Tomography, X-Ray Computed; Treatment Outcome	2004

Article

Year

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.

Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6

Topics: Adolescent; Adult; Aniline Compounds; Antineoplastic Agents; Central Nervous System Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Nitriles; Tomography, X-Ray Computed; Treatment Outcome

2004